Cadence Bank - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 789 filers reported holding GLAXOSMITHKLINE PLC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cadence Bank ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q4 2019$265,000
+12.3%
5,637
+2.0%
0.05%
+122.7%
Q3 2019$236,000
+1.3%
5,524
-1.0%
0.02%
-4.3%
Q1 2019$233,000
-15.6%
5,582
-22.7%
0.02%
-28.1%
Q4 2018$276,000
-16.6%
7,220
-12.3%
0.03%
+3.2%
Q3 2018$331,000
-9.8%
8,230
-9.5%
0.03%
-6.1%
Q2 2018$367,000
+15.4%
9,098
+11.9%
0.03%
+10.0%
Q1 2018$318,000
-1.9%
8,132
-11.0%
0.03%
-3.2%
Q4 2017$324,0009,1320.03%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2018
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 668,200$30,717,0009.01%
Camber Capital Management LP 1,200,000$55,164,0005.18%
Camber Capital Management LP 1,000,000$45,970,0004.32%
Gary Goldberg Planning Services Inc 178,496$8,205,0003.41%
Hamlin Capital Management, LLC 1,217,870$55,985,0003.36%
Winch Advisory Services, LLC 109,101$5,015,0003.22%
NORTHROAD CAPITAL MANAGEMENT LLC 151,701$6,974,0002.69%
Reynders McVeigh Capital Management, LLC 296,118$13,613,0002.59%
SALEM CAPITAL MANAGEMENT INC 120,520$5,540,0002.58%
Keystone Financial Planning, Inc. 74,338$3,417,0002.58%
View complete list of GLAXOSMITHKLINE PLC shareholders